Healthcare -
Biotechnology - NASDAQ - US
$ 6.18
-4.48 %
$ 629 M
Market Cap
-13.15
P/E
TRVI - NET INCOME
Net Income TRVI - Trevi Therapeutics, Inc.
-47.9 M
LAST VALUE
-28.20%
2 YEAR CAGR
-12.96%
5 YEAR CAGR
0.00%
10 YEAR CAGR